EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimizing Diagnostic Accuracy of Clinical Red Flags in RASopathies

Emanuele Bobbio iD, Martina Caiazza, Emanuele Monda iD, Giustina Aruta, Alberto Budillon, Augusto Esposito iD, Adelaide Fusco, Annapaola Cirillo, Marta Rubino, Immacolata Viscovo, Gioacchino Scarano, Matteo Della Monica und 5 weitere

American Journal of Medical Genetics Part A · 2026-07 · 200 (7) · 1608-1618

DOI: 10.1002/ajmg.a.70119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 11.03.2026. Verfasst von Emanuele Bobbio und 16 weiteren Autor:innen. Beteiligte Einrichtung: Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Monaldi Hospital…. Hauptthemen laut MEDLINE: Noonan Syndrome, Protein Tyrosine Phosphatase, Non-Receptor Type 11, Heart Defects, Congenital, ras Proteins. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Heart-Lung Foundation, Swedish Society of Cardiology, Hjärt-Lungfonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RASopathies are a group of genetic disorders caused by pathogenic variants in the RAS‐mitogen‐activated protein kinase (RAS–MAPK) signaling pathway, often presenting with congenital heart defects, craniofacial dysmorphisms, and developmental delays. To assess the diagnostic yield of genetic testing in patients with suspected RASopathies and to identify predictive clinical “red flags” using machine learning (ML). This retrospective study included patients evaluated at our institution between 2020 and 2023. All patients underwent cardiovascular evaluation, and a subset of individuals with suspected RASopathies underwent genetic assessment including exome sequencing. Thirteen clinical “red flags” were analyzed as predictors of a molecular diagnosis within the subgroup of patients with suspected RASopathies. Diagnostic performance was assessed via sensitivity, specificity, and area under the curve (AUC). A random forest classifier identified the most predictive clinical features. Among 669 patients, 34 were clinically suspected of RASopathy, with a confirmed diagnosis in 24 cases (71%). Noonan syndrome was most frequent (18/24), and PTPN11 was the most commonly mutated gene ( n = 13). Pulmonary valve stenosis (PVS) and facial dysmorphisms were the strongest individual predictors of a positive genetic test result. A threshold of ≥ 2 red flags balanced sensitivity (92%) and accuracy (73.5%). ML analysis identified PVS and facial dysmorphisms as the top predictors. A model including only these features achieved an AUC of 0.86 in the derivation cohort. PVS and facial dysmorphisms are key diagnostic indicators for RASopathies and should prompt early genetic testing. While the ML model showed high performance in this derivation cohort, external validation is needed to confirm its generalizability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Noonan SyndromeProtein Tyrosine Phosphatase, Non-Receptor Type 11Heart Defects, Congenitalras ProteinsPulmonary Valve StenosisHumansFemaleMaleMutationChild, PreschoolRetrospective StudiesInfantGenetic TestingChildMachine LearningExome SequencingRandom Forest

Stichwörter der Autor:innen

NoonanRAS signalingRASopathygeneticsinherited cardiac conditionsmachine learningred flags

Substanzen

Protein Tyrosine Phosphatase, Non-Receptor Type 11PTPN11 protein, humanras Proteins

Autor:innen und Institutionen

  • Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Monaldi Hospital, Naples, Italy.
  • Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Unità Operativa Semplice Dipartimentale (UOSD) Genetica Medica, Azienda Ospedaliera di Rilievo Nazionale (AORN), Benevento, Italy.
  • Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.
  • Research Unit of Intelligent Health Technology for Health and Wellbeing, Department of Engineering, Università Campus Bio-Medico di Roma, Rome, Italy.
  • School of Engineering, University of Warwick, Coventry, UK.

ORCID-Profile: Emanuele Bobbio, Emanuele Monda, Augusto Esposito, Giuseppe Limongelli

Förderung

  • Swedish Heart-Lung Foundation
  • Swedish Society of Cardiology
  • Hjärt-Lungfonden

Zitieren

APA

Bobbio, E., Caiazza, M., Monda, E., Aruta, G., Budillon, A., Esposito, A., Fusco, A., Cirillo, A., Rubino, M., Viscovo, I., Scarano, G., Monica, M. D., Nigro, V., Piluso, G., Pecchia, L., Russo, M. G., & Limongelli, G. (2026). Optimizing Diagnostic Accuracy of Clinical Red Flags in RASopathies. American Journal of Medical Genetics Part A, 200(7), 1608-1618. https://doi.org/10.1002/ajmg.a.70119

Vancouver

Bobbio E, Caiazza M, Monda E, Aruta G, Budillon A, Esposito A, et al. Optimizing Diagnostic Accuracy of Clinical Red Flags in RASopathies. American Journal of Medical Genetics Part A. 2026;200(7):1608-1618. doi:10.1002/ajmg.a.70119

BibTeX
@article{Bobbio2026,
  author = {Bobbio, Emanuele and Caiazza, Martina and Monda, Emanuele and Aruta, Giustina and Budillon, Alberto and Esposito, Augusto and Fusco, Adelaide and Cirillo, Annapaola and Rubino, Marta and Viscovo, Immacolata and Scarano, Gioacchino and Monica, Matteo Della and Nigro, Vincenzo and Piluso, Giulio and Pecchia, Leandro and Russo, Maria Giovanna and Limongelli, Giuseppe},
  title = {Optimizing Diagnostic Accuracy of Clinical Red Flags in RASopathies},
  journal = {American Journal of Medical Genetics Part A},
  year = {2026},
  volume = {200},
  number = {7},
  pages = {1608--1618},
  doi = {10.1002/ajmg.a.70119}
}
Kostenlos starten →